Upgrade to SI Premium - Free Trial

Vaxart (VXRT)

0.32 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/29/26)

Latest Headlines

Form 4 Vaxart, Inc. For: Oct 16 Filed by: Bono Raquel C. October 20, 2026 7:05 PM - SEC Filing Form 3 Vaxart, Inc. For: Oct 16 Filed by: Bono Raquel C. October 20, 2026 7:04 PM - SEC Filing Form 8-K Vaxart, Inc. For: Oct 16 October 19, 2026 4:07 PM - SEC Filing Vaxart adds retired vice admiral and surgeon to its board October 19, 2026 8:01 AM - StreetInsider Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors October 19, 2026 8:00 AM - Globe NewsWire Vaxart publishes H5N1 oral vaccine preclinical data in ferrets October 8, 2026 8:41 AM - StreetInsider Vaxart Announces Publication of Preclinical Study Demonstrating 100% Protection Against a Lethal Dose of H5N1 Avian Flu in a Ferret Challenge Model October 8, 2026 8:40 AM - Globe NewsWire Form 8-K Vaxart, Inc. For: Sep 03 September 22, 2026 5:10 PM - SEC Filing Form 8-K Vaxart, Inc. For: Sep 03 September 14, 2026 4:06 PM - SEC Filing Vaxart receives European patent for oral norovirus vaccine technology August 26, 2026 4:08 PM - StreetInsider Vaxart Expands Intellectual Property Portfolio with European Patent Protecting Proprietary Norovirus Vaccine Technology August 26, 2026 4:07 PM - Globe NewsWire Form 8-K Vaxart, Inc. For: Aug 21 August 25, 2026 4:13 PM - SEC Filing Vaxart (VXRT) Misses Q2 EPS by 3c August 6, 2026 5:03 PM - StreetInsider Form 10-Q Vaxart, Inc. For: Jun 30 August 6, 2026 4:33 PM - SEC Filing Form 8-K Vaxart, Inc. For: Aug 06 August 6, 2026 4:24 PM - SEC Filing Vaxart Provides Business Update and Reports Second Quarter 2026 Financial Results August 6, 2026 4:06 PM - Globe NewsWire Vaxart to Host Stockholder Fireside Chat on August 7 at 4:30 p.m. ET July 30, 2026 8:00 AM - Globe NewsWire Form 8-K Vaxart, Inc. For: Jul 27 July 28, 2026 8:00 AM - SEC Filing Full Article List